Introduction
In the eukaryotic cell cycle, D-type cyclins (D1, D2, D3) and cyclin E are involved in regulating G1 phase progression and entry into S phase (Sherr, 1994) . Cdks that control mammalian G1 progression include the catalytic subunit Cdk2 associated with the activating subunit cyclin E and Cdk4 or its isoform Cdk6 associated with any one of the three cyclin D isoforms (Morgan, 1994) . These complexes become activated upon phosphorylation of the Cdk subunit by CAK (Cdk Activating Kinase), itself a Cdk-related kinase complex (Pines, 1995) . These cyclin-Cdk complexes can positively regulate the cell cycle by phosphorylating pRb and thereby inhibit the activity of this cell cycle regulator (Sherr, 1994; Weinberg, 1995) . One further level of control is dependent of proteins that bind to and inhibit the catalytic activity of cyclin-Cdk complexes (Sherr and Roberts, 1995) . These inhibitors (Ckis) induce cell cycle arrest in response to anti-proliferative signals (Polyak et al., 1994; Reynisdottir et al., 1995) and cell dierentiation (Parkers et al., 1995; Liu et al., 1996; Lee et al., 1996) . Ckis are divided in two families (Sherr and Roberts, 1995; Xiong, 1996) . The Ink4 family includes p15 Ink4b , p16 Ink4a , p18
Ink4c that speci®cally bind and inhibit Cdk4 and Cdk6 and p19
ARF that has a tumor suppression function dependent upon the p53. p21 Cip1 , p27
Kip1 and p57 Kip2 , members of the Cip/Kip family, inhibit all G1/S phases cyclin-Cdks complexes (Harper and Elledge, 1996; Sherr, 1996; Toyoshima and Hunter, 1994) . p21 Cip1 , p27
Kip1 and p57 Kip2 all promote the association of Cdk4/Cdk6 with the D-type cyclins. The promotion of assembly requires the function of both the Cdk and cyclin-binding domains. As recently shown, a separate non-catalytic action of cyclin D-dependent kinase is the sequestration of Ckis, including p21
Cip1 and p27
Kip1
. The p21
Cip1 and p27 Kip1 found to be inhibitors of Cdks are essential activators of cyclin D-dependent kinases in murine ®broblasts (Cheng et al., 1999) . p21 Cip1 can associate with cyclin-Cdk kinases in two functionally distinct forms. At low concentrations, p21
Cip1 promotes the assembly of active kinase complexes, whereas at higher concentrations, it inhibits the kinase activity of cyclin-Cdk complexes, (Lin et al., 1996; LaBaer et al., 1997) . A ratio of two p21 molecules per Cdk seems to be required for inhibition, whereas a single molecule has no inhibitory eect Zhang et al., 1994) . Furthermore, in extracts of ®broblasts, the majority of the cyclin E-Cdk2 complexes can be immunodepleted with anti p21 antibodies (Harper et al., 1995). p27 Kip1 in the same conditions, can inhibit cyclin E-Cdk2, at low concentrations but not cyclin D2-Cdk4 (Blain et al., 1997) . The structure of p27 Kip1 bound to cyclin A-Cdk2 suggests that one molecule should be sucient to repress kinase activity (Russo et al., 1996) . Recently, it has been demonstrated that p57 Kip2 at lower concentrations interacts with catalytically active cyclin A-Cdk2 complexes, but kinase activity was quenched when more wild-type p57
Kip2 was added (Hashimoto et al., 1998) . These results are consistent with the reported bimodal association of p21 Cip1 with cyclin-Cdk complexes . Although a structure of p21 Cip1 and p57 Kip2 has not yet been reported, the Cip/Kip proteins interact with a variety of cyclin-Cdk complexes through a conserved N-terminal domain that contains both cyclin and Cdk binding sites (Hengst and Reed, 1998) . In this report we also examined the ability of p57
Kip2 to form dimers in vitro and in vivo. We found that the a-helix domain located in the NH2 terminal region is necessary and sucient to form p57 Kip2 homodimers. We show that the increasing levels of p57
Kip2 homodimerization lead to a signi®cant increase in the amounts of p57 which a low level of p57 Kip2 seems to be required for assembly of active cyclin D1-Cdk4 complexes and that the a-helix is implicated in the formation of p57 Kip2 homodimers that inhibit cyclin D1-Cdk4 kinase activity.
Results and discussion

p57
Kip2 interacts with itself by its NH2 terminal domain
In order to test whether p57 Kip2 could form homodimers in vitro, a GST-pull down assay was performed. GST or GST-p57
Kip2
-covered beads were incubated with 35 S-labeled in vitro-translated p16
Ink4a
, p57
Kip2 or cyclin D1 (Figure 1 ). Cyclin D1, taken as a positive control interacts with GST-p57
Kip2 but not with GST alone while no speci®c binding was found between p16
Ink4a and GST-p57
Kip2
. Interestingly, in the same conditions, a signi®cant amount of binding (about 12 ± 15% of the input) could be detected when 35 S-labeled p57
Kip2 was added individually with GST-p57 Kip2 while no speci®c binding was found with GST alone ( Figure  1 , lanes 8 and 9). These data show that in vitro p57 Kip2 but not p16
Ink4a is able to interact with p57
.
In order to verify if p57
Kip2 can associate with itself in vivo, C3H10T1/2 cells were transiently transfected with pCMV-Flag-p57
Kip2 and pCMV-HA-p57 Kip2 alone or in combination and the dierently tagged proteins were ®rst immunoprecipitated with the anti-Flag antibodies. Then, the immune complexes were analysed by Western blotting using the anti-HA antibodies. As shown in Figure 2 , HA-p57
Kip2 was only immunoprecipitated with anti Flag antibodies when cells had been cotransfected with pCMV-Flag-p57
Kip2 and pCMV-HAp57
Kip2 (Figure 2 , lane 4). Kip2 required for its self-association, various Kip2 fusion proteins containing either the wild-type p57
Kip2 protein (wt), the complete Cdk inhibitor domain (CKI), the prolin-rich and acidic repeat domains (PAC), the QT domain (QT) or the mutants deleted in each domain (DCKI, DQT, DPAC) were tested for binding to in vitro translated p57 Kip2 ( Figure 3 ). Cyclin D1 was used as a positive binding control. The results are shown in Figure 3A ,B and summarized in Figure 3C . They show that the NH2 domain containing the cyclin/Cdk binding sites is necessary and sucient to p57
Kip2 homodimerization. The COOH-terminus of p57
Kip2 (also termed QT box) is distinct from the carboxyl-terminal region of p21
Cip that is involved in PCNA binding but it is related to the carboxyl terminus of p27
Kip1 (Matsuoka et al., 1995) . Sequence conservation with p27
Kip1 indicates that this COOH region is a structural motif, including an ankyrin domain that is likely to function in protein ± protein interactions (Kerr et al., 1992) . Surprisingly, our data strongly suggest that whether the COOH domain of p57
Kip2 is implicated in a particular activity, it is not implicated in the homodimer formation.
p57
Kip dimers formation is not disrupted by binding to cyclin D1-Cdk4 complexes The experiments described above suggest that p57 Kip2 could bind either to cyclin or Cdk binding sites and/or the both that are located in the NH2 domain of p57 Kip2 and/or outside these sites. To test these hypotheses, we took advantage of an in vitro association/competition assay as described in Materials and methods. Brie¯y, Figure 1 Binding of p57
Kip2 to GST-p57 Kip2 in vitro. Expression vectors encoding cyclin D1, p16
Ink4a and p57 Kip2 were in vitrotranslated by programmed reticulocyte lysates and 2 ml of the products were analysed by SDS ± PAGE (lanes 1 ± 3). Equimolar amounts of labeled proteins were incubated with beads covered with GST (7), lanes 4, 6 and 8) or Kip2 (+), lanes 5, 7 and 9). Binding assays were carried out in a highest stringency condition with 150 mM NaCl and 0.5% Nonidet P40 in binding buer. Bound proteins were analysed by SDS ± PAGE and autoradio¯uorography Kip2 coprecipitates with Flag-p57 Kip2 in vivo. C3H10T1/2 were transiently transfected with an empty vector (lane 1). Kip2 alone (lane 2), HA-p57 Kip2 alone (lane 3) or with HA-p57
Kip2 and Flag-p57 Kip2 together (lane 4). Aliquots of total cell extract (A) 10 mg and (B) 30 mg were analysed by Western blot with the anti-Flag antibodies or antibodies directed to the HA epitope respectively. (c) 400 mg of total extracts from the transiently transfected cells were immunoprecipitated using the anti-Flag antibodies and then immunoprecipitates were analysed by Western blotting using the anti-HA monoclonal antibodies Kip2 covered beads were ®rst incubated with 35 S-labeled-p57 Kip2 and unbound p57 Kip2 is removed prior to addition of cyclin and Cdk and then increasing amounts of cyclin D1, Cdk4 or cyclin D1-Cdk4 complexes were added. As shown in Figure 4B , addition of cyclin D1 alone, Cdk4 alone or cyclin D1-Cdk4 complexes did not disrupt p57
Kip2 homodimers formation ( Figure 4B, lanes 3 ± 11) . These results strongly suggest that cyclin D1-Cdk4 complexes do not compete with p57 Kip2 homodimerization.
Although physical interaction between p57
Kip2 molecules may occur via a domain outside the cyclin-Cdk binding sites in the amino terminus of the Cki, our results indicate that the binding of cyclin-Cdk complexes does not modify p57 Kip2 ± p57 Kip2 association. Our data correlate with a previous report showing that a peptide covering amino acids 21 ± 45 of p21 Cip , a region located between the cyclin and the Cdk binding sites, could be a potential multimerization domain of p21 Cip1 (Chen et al., 1996) . This peptide region has a considerable tendency to take an a-helical conformation, indicating that this domain is in a coiled conformation in the native protein. Such a coiled conformation is also observed in p27
Kip1 and in p57
Kip2 proteins (Russo et al., 1996) .
The integrity of the a-helix in NH2 region is indispensable for p57 Kip2 dimer formation
In an attempt to test the hypothesis that the a-helix (aa 26 ± 47) is required for dimer association, we generated a replacement of the conserved arginine at position 33 by a leucine (R33L) in the a-helix domain of the GSTp57 Kip2 fusion protein and tested by GST pull down its ability to associate with 35 S-labeled p57
Kip2 proteins. As shown in Figure 5 , substitution of arginine for leucine in the p57 Kip2 molecule dramatically reduced the binding of (
S) p57
Kip2 wild-type while this mutant retained the ability to bind cyclin D1-Cdk4 complexes and no signi®cant binding was observed with GST alone. These data suggest that the a-helix domain seems to play a major role in p57
Kip2 homodimerization. Preliminary data strongly suggest that the substitution of Arg 33 by Leu enhances the stability of the a-helix thus modifying the interaction between p57
Kip2 molecules (manuscript in preparation).
p57
Kip2 dimerization inhibits kinase activity of cyclin D1-Cdk4 complexes in vivo It has been reported that Ckis can be components of catalytically active kinase complexes suggesting that they have another role than their function as Ckis. To determine whether p57
Kip2 homodimerization is associated with one of these two functions and to assay only the exogenous proteins, we transiently transfected C3H10T1/2 ®broblasts by maintaining constant levels of HA-cyclin D1, HA-CdK4 and Flag-p57
Kip2 while increasing the levels of HA-p57
Kip2
. We then immunoprecipitated the complexes by the Flag antibodies and measured associated kinase activity. To assess Flagp57
Kip2 -HA-p57
Kip2 complex assembly in the same lysates, we also examined the coimmunoprecipitation of HA-p57
Kip2 . In the absence of tagged proteins no complex formation and minimal kinase activity were observed ( Figure 6, lane 1) . In the presence of low levels of HA-p57
Kip2 hardly detectable complex formation with Kip2 was found but we observed elevated kinase activity which was much higher than the one of the same lysate precipitated by anti-cycin Figure 3 The NH2 terminal domain of p57
Kip2 is sucient for homodimerization. (A) Kip2 deletion mutants were produced in E. coli and similar amounts of the various GSTp57
Kip2 fusion proteins bound to glutathione-agarose were incubated with Kip2 were in vitro-translated by programmed reticulocyte lysates and 2 ml of the products were analysed by SDS ± PAGE. (B) Five microliters of p57
Kip2 were preincubated with 2 mg of GST alone (lane 1) or GST-p57
Kip2 fusion protein (lanes 2 ± 11) for 2 h at 48C. Cdk4 alone (lanes 3 ± 5), cyclin D1 alone (lanes 6 ± 8) or cyclin D1-Cdk4 (lanes 9 ± 11) were synthesized in reticulocyte lysates separately or together and then 1, 3 and 6 ml of extracts were added to the binding reaction and incubation was further continued for 1 h. Binding assays were carried out as described in Figure 1 D1 ( Figure 6 , lane 5). At much higher levels, HAp57
Kip2 induced maximal complex formation with Flagp57 Kip2 and reduced kinase activity were observed ( Figure 6, lanes 2 ± 4) . By comparing the amount of formed complexes to the relative kinase activity, interesting features appear with regard to the eect of p57 dimer formation on kinase activity. Although in Figure 6 , lanes 2 ± 4, we demonstrate an equivalent amount of cyclin D1-Cdk4 complexes, the coimmunoprecipitation of constant Flag-p57
Kip2 with increasing HA-p57
Kip2 induced a decrease in kinase activity. This is consistent with the model proposed by Zhang et al. (1994) showing that as additional molecules of p21 are added to active p21-containing complexes, kinase activity is inhibited.
In conclusion, we have provided biochemical evidence that p57
Kip2 homodimerizes in vitro and in vivo. Our results strongly suggest that in vitro p57 Kip2 homodimerizes without cyclin/Cdk complexes and in the presence of increasing amounts of cyclin D1/Cdk4 complexes, homodimerization of p57
Kip2 is not disrupted. Speci®c and functional interactions demonstrate direct interaction of p57
Kip2 molecules via the NH2 terminal region containing the conserved a-helix domain that may form the basis of a molecular mechanism by which the Cip/Kip proteins family regulates the cyclin/Cdk kinase activity. Our data plead in favor of reports on the necessity of two inhibitor molecules per cyclin-Cdk complex for kinase inhibition.
Materials and methods
Cell culture and transfections
The ®broblastic cell line C3H10T1/2 was maintained in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 15% fetal calf serum (Valbiotech) and antibiotics (penicillin/streptomycin from Gibco) used according to manufacturer's recommendations. Cells were plated in 6-well plates and transfected by PEI (Boussif et al., 1995) with a total of 12 mg of various combinations of plasmids DNA per well as indicated in the legend of the ®gures. The total amount of DNA used for each plate was normalized with the respective empty expression plasmids. One hundred nanograms of the pEGFP-C1 plasmid (Invitrogen) was included in transfections as an internal control for transfection eciency.
Plasmids construction
pEX10X-p57
Kip2
, and pBIISK-p27
Kip1 were kindly supplied by J MassagueÂ . pCEP-WAF1 was generously donated by B Vogelstein. CMV-p16
Ink4a was a kind gift from B Heinglein. Cyclin D1 was kindly supplied by C Sherr. To create expression vectors, fragments containing the entire coding sequences were cloned into pcDNA3 expression vectors (In Vitrogen).
Expression vectors pCMV-HA-p57
, pCMV-HA-Cdk4 and pCMV-HA-cyclin D1 were generated by cloning three hemaglutinin epitope tags (3Tag HA) at the amino terminus of cDNA inserts in pcDNA3. Expression vector pCMV-Flag Figure 5 Comparative binding of p57
Kip2 wild-type and cyclin D1-Cdk4 complexes to the GST fusion proteins p57
Kip2 wild-type and the mutant R33L. Expression vectors encoding the cyclin D1-Cdk4 complex and p57
Kip2 were in vitro-translated by programmed reticulocyte lysates and 2 ml of the products were analysed by SDS ± PAGE (lanes 1 and 2) . Equimolar amounts of labeled proteins were incubated with beads covered with GST (lane 3) GST-p57 wild-type (lane 4) or GST-p57-R33L (lane 5). Binding assays were carried out as described in Figure 1 Figure 6 p57 Kip2 assembly inhibits the activity of cyclin D1-Cdk4 complexes in vivo. (A) Asynchronous populations of C3H10T1/2 cells were transiently transfected with equal amounts (2 mg) of plasmids encoding HA-Cdk4, HA-cyclin D1 and Flagp57
Kip2 and increasing amounts of expression vectors encoding HA-p57 Kip2 (1 mg, 3 mg and 6 mg; lanes 2 ± 4). Complexes assembly was assayed by IP-Western blot assay. Comparative expression levels were demonstrated by Western blots. (B) Complexes were immunoprecipitated through the Flag epitope and kinase reactions were performed using 1 mg of GST-Rb protein as substrate. A duplicate sample of lane 2 was also immunoprecipitated by anti-cyclin D1 antibodies and used as standard control of kinase reaction (lane 5) was generated by cloning the Flag epitope at the amino terminus of cDNA insert in pCDNA3. Constructions of pGEX-2TK-p57
Kip2 and pGEX-p57 mutants are available upon request. pGEX-p57-R33L was generated by PCR with a 5' primer (5'-GAGCTGGGCCTCGAGCTGCGGATGC-3') and a 3' primer (5'-GCATCCGCAGCTCGAGGCC-CAGCTC-3') using pGEX-2TK-p57
Kip2 wild-type as template.
Protein expression, purification and GST pull-down assay Bacterial expression of proteins was performed in E. coli BL21 DE3. Protein induction, cell lysates, and anity puri®cation with glutathione-agarose beads (Sigma) were done as described previously (Lassar et al., 1995) except that bound proteins were not eluted. , cyclin D1, Cdk4 or cyclin D1-Cdk4 complexes were prepared by coupled in vitro transcriptiontranslation using the TnT coupled rabbit reticulocyte lysate system (Promega). GST pull-down assays were performed as described previously (Lenormand et al., 1997 proteins were removed by three wash cycles of binding buer. Then increasing amounts of labeled cyclin D1, Cdk4 or cotranslated cyclin D1-Cdk4 complexes were added to the binding reactions and the resulting mixtures were subjected to a GST pull-down assay. The reaction products were separated on SDS ± PAGE. Bound proteins were detected by autoradio¯uorography and quanti®ed by using PhosphorImager.
Immunoprecipitation and immunoblotting
Immunoprecipitation was performed as previously described (Lenormand et al., 1997) . Before immunoprecipitation, aliquots from each sample were loaded onto a 10% SDS ± PAGE and analysed by immunoblotting to test the expression of HA-tagged proteins (10 mg) and Flag-tagged proteins (30 mg) respectively. Four hundred micrograms of total cell lysate were immunoprecipitated with anti-Flag antibodies (M2, Eastman Kodak). The immunoprecipitates were separated by SDS ± PAGE and proteins were transferred onto nitrocellulose membranes. Immunodetection was performed with the anti-HA monoclonal antibody (12CA5, dilution: 1/1000, Boehringer Mannheim) or the M2 anti-Flag antibody (dilution: 1/330). Membranes were washed and incubated for 1 h with a peroxydase-conjugated secondary antibody (Sigma). After several washes, membranes were incubated with chemiluminescence reagents (ECL, Amersham Corp.).
Kinase assay
Immunoprecipitates were washed twice in kinase buer (50 mM HEPES, pH 8., 10 mM MgCl 2 , 2.5 mM EGTA, 1 mM dithiothreitol, 10 mM b-glycerophosphate, 1 mM NaF, 0.1 mM Na 3 VO 4 , 0.1 mM PMSF, 50 mM ATP and 150 kBq of [g 32 P]-ATP) (3000 Ci/mMole, Amersham Corp.). Kinase activity was determined at 308C for 30 min in 25 ml of kinase buer. One microgram of GST-pRb was used as substrate. The reaction products were separated on SDS ± PAGE. Phosphorylated proteins were detected by autoradiography and quanti®ed by using PhosphorImager.
